🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1571Source: DataRank Database

Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation is a research paper published in Cancer Discovery (2021). On theSindex it has a DataRank of 0. It has been cited 132 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access132 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)OA: bronzeTopics (57)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Fang Hua ORCID,Xiong Li ORCID,Jian Zhang ORCID,Shasha Li ORCID,Weichao Wang ORCID

Live enrichment

PubMed:33627378

National Cancer Institute National Institutes of Health

Grant: R01CA217648

National Cancer Institute National Institutes of Health

Grant: R01CA123088

National Cancer Institute National Institutes of Health

Grant: R01CA099985

National Cancer Institute National Institutes of Health

Grant: R01CA193136

National Cancer Institute National Institutes of Health

Grant: R01CA152470

University of Michigan Rogel Cancer Center Grant

Grant: CA46592

National Institutes of Health

Grant: 5R01CA123088-05

Novel immunosupressive macrophages in human ovarian tumor

National Institutes of Health

Grant: 5R01CA099985-02

Human Tregs in Ovarian Cancer

Wellcome Trust

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R01CA152470-02

Memory T Cells in the Tumor Microenvironment

National Institutes of Health

Grant: 5R01CA193136-02

MDSCs in Ovarian Cancer

NCI NIH HHS

Grant: P30 CA046592

NCI NIH HHS

Grant: R01 CA217510

NCI NIH HHS

Grant: R01 CA214911

NCI NIH HHS

Grant: T32 CA009672

NCI NIH HHS

Grant: R01 CA248430

NCI NIH HHS

Grant: R01 CA211016

bronze

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/11/7/1826/3105854/1826.pdf

repositoryhttps://hdl.handle.net/2027.42/191680

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8292167

https://doi.org/10.1158/2159-8290.cd-20-1571

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292167

Fields of Study

03 medical and health sciences0302 clinical medicineAnimalsCell Cycle ProteinsColorectal NeoplasmsFemaleHistocompatibility Antigens Class IHumansInterferon-gammaLipoylationMaleMembrane Transport ProteinsMiceMice, Inbred C57BLMice, Inbred StrainsProtein TransportReceptors, InterferonSpecific Pathogen-Free OrganismsInterferon gamma Receptor

MeSH Terms

AnimalsCell Cycle ProteinsColorectal NeoplasmsFemaleHistocompatibility Antigens Class IHumansInterferon-gammaLipoylationMaleMembrane Transport ProteinsMiceMice, Inbred C57BLMice, Inbred StrainsProtein TransportReceptors, InterferonSpecific Pathogen-Free OrganismsInterferon gamma Receptor

Keywords

MaleLipoylationHistocompatibility Antigens Class IInbred StrainsMembrane Transport ProteinsCell Cycle ProteinsMice, Inbred StrainsInbred C57BLSpecific Pathogen-Free OrganismsMice, Inbred C57BLInterferon-gammaMiceProtein TransportReceptorsInterferonAnimalsHumansFemaleColorectal NeoplasmsInterferon gamma ReceptorReceptors, Interferon

Sustainable Development Goals

SDG 3: 3. Good health